In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann ...

The first partner company is on the path to market, but the implications are clear: eXoZymes has created a scalable production engine for molecules that were previously too rare or expensive to make.

The proposed designs were then synthesised and tested in the lab where they achieved enzymatic activities close to those ...

According to a new study published in the journal Frontiers in Endocrinology, researchers have found that a commonly measured ...

Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes ...

Researchers at the Department of Cell and Molecular Biology, Karolinska Institutet have captured the first detailed molecular ...

For decades, Arieh Warshel, USC Distinguished Professor of Chemistry and a 2013 Nobel laureate, has used computer simulations ...

By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...

That’s the big idea behind Zymosense, “The Nanoassay Company,” a startup that’s spinning off technology developed in the lab ...

Scott Nelson, left, and Nathaniel Kallmyer work in the laboratory of Zymosense, a startup company based in the Iowa State ...

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

By Priyanjana Pramanik, MSc. Common blood test results may offer an early clue to bone loss, suggesting that alkaline ...